Skip to main content

Agitation News (Page 5)

Physical Restraint Use More Likely for Black Adults in Emergency Departments

WEDNESDAY, Sept. 27, 2023 – In adult emergency departments, physical restraint is uncommon but occurs more often among Black patients than White and non-Black patients, according to a review...

FDA Approves Igalmi (dexmedetomidine) Sublingual Film for Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I or II Disorder in Adults

NEW HAVEN, Conn., April 06, 2022 (GLOBE NEWSWIRE) – BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence (AI) approaches to identify and develop...

FDA Approves Adasuve (loxapine) Inhalation Powder for the Acute Treatment of Agitation Associated with Schizophrenia or Bipolar I Disorder in Adults

MOUNTAIN VIEW, Calif., Dec. 21, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Adasuve (loxapine) Inhalation Powder 10 mg ...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Agitated State

Related drug support groups

citalopram, olanzapine, risperidone